ArticleBlood neoplasia2025

Phase 2 trial of daratumumab, cyclophosphamide, thalidomide, and dexamethasone in newly diagnosed multiple myeloma.

Edvan de Queiroz Crusoé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.